Cognitive impairment in bipolar disorder treated with aripiprazole

Trial Profile

Cognitive impairment in bipolar disorder treated with aripiprazole

Completed
Phase of Trial: Phase II

Latest Information Update: 29 Aug 2016

At a glance

  • Drugs Aripiprazole (Primary)
  • Indications Cognition disorders
  • Focus Therapeutic Use
  • Acronyms CIBA
  • Sponsors Bristol-Myers Squibb
  • Most Recent Events

    • 14 Jan 2014 According to European Clinical Trials Database status changed from recruiting to completed.
    • 26 Sep 2012 New source identified and integrated (German Clinical Trials Register: DRKS00004316).
    • 24 Apr 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top